Unspecified Medications (All Other Therapeutic Products)


Combined with:

Rebif

Indications and Reactions:

Role Indications Reactions
Secondary
Ill-defined Disorder 22.2%
Multiple Sclerosis 22.2%
Pain 22.2%
Depression 11.1%
Product Used For Unknown Indication 11.1%
Type 2 Diabetes Mellitus 11.1%
Hypoglycaemia Neonatal 25.0%
Overdose 25.0%
Somnolence 25.0%
Urinary Tract Infection Fungal 25.0%
Concomitant
Multiple Sclerosis 90.1%
Drug Use For Unknown Indication 2.1%
Diarrhoea 1.0%
Secondary Progressive Multiple Sclerosis 1.0%
Anticoagulant Therapy 0.5%
Bipolar Disorder 0.5%
Dementia 0.5%
Gout 0.5%
Hypercholesterolaemia 0.5%
Hypertension 0.5%
Influenza Immunisation 0.5%
Insomnia 0.5%
Oesophageal Disorder 0.5%
Pain 0.5%
Product Used For Unknown Indication 0.5%
Urinary Tract Infection 14.1%
Pneumonia 10.6%
Weight Decreased 10.6%
Multiple Sclerosis Relapse 8.2%
Multiple Sclerosis 7.1%
Sleep Apnoea Syndrome 7.1%
Vomiting 5.9%
Convulsion 3.5%
Myocardial Infarction 3.5%
Pyrexia 3.5%
Suicidal Ideation 3.5%
Tremor 3.5%
Fatigue 2.4%
Lower Limb Fracture 2.4%
Metastases To Pancreas 2.4%
Muscular Weakness 2.4%
Nephrolithiasis 2.4%
Pain In Extremity 2.4%
Prothrombin Time Prolonged 2.4%
Renal Failure 2.4%

Drug Data